- Company Overview for BXTA NANOTHERAPY LTD (14533667)
- Filing history for BXTA NANOTHERAPY LTD (14533667)
- People for BXTA NANOTHERAPY LTD (14533667)
- More for BXTA NANOTHERAPY LTD (14533667)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
09 May 2024 | SH01 |
Statement of capital following an allotment of shares on 9 May 2024
|
|
11 Apr 2024 | AA | Accounts for a small company made up to 30 June 2023 | |
26 Mar 2024 | SH01 |
Statement of capital following an allotment of shares on 25 March 2024
|
|
13 Mar 2024 | SH01 |
Statement of capital following an allotment of shares on 11 March 2024
|
|
10 Jan 2024 | CS01 | Confirmation statement made on 8 December 2023 with updates | |
07 Nov 2023 | SH01 |
Statement of capital following an allotment of shares on 31 October 2023
|
|
04 Aug 2023 | SH01 |
Statement of capital following an allotment of shares on 1 August 2023
|
|
12 Apr 2023 | SH01 |
Statement of capital following an allotment of shares on 28 March 2023
|
|
07 Feb 2023 | MA | Memorandum and Articles of Association | |
07 Feb 2023 | RESOLUTIONS |
Resolutions
|
|
02 Feb 2023 | SH01 |
Statement of capital following an allotment of shares on 30 January 2023
|
|
02 Feb 2023 | AP01 | Appointment of Mr Jonathan Coulter as a director on 30 January 2023 | |
02 Feb 2023 | AP01 | Appointment of Mr David Moore as a director on 30 January 2023 | |
10 Dec 2022 | AA01 | Current accounting period shortened from 31 December 2023 to 30 June 2023 | |
09 Dec 2022 | NEWINC |
Incorporation
Statement of capital on 2022-12-09
|